Product NDC: | 62037-777 |
Proprietary Name: | clarithromycin |
Non Proprietary Name: | clarithromycin |
Active Ingredient(s): | 500 mg/1 & nbsp; clarithromycin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62037-777 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065145 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080101 |
Package NDC: | 62037-777-60 |
Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-777-60) |
NDC Code | 62037-777-60 |
Proprietary Name | clarithromycin |
Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-777-60) |
Product NDC | 62037-777 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clarithromycin |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080101 |
Marketing Category Name | ANDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | CLARITHROMYCIN |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |